17b-estradiol (E 2 ) is thought to be responsible for sex-specific differences in skeletal muscle mass. The biological function of E 2 is exerted through its binding to estrogen receptor a (ERa). The expression of ubiquitin-specific peptidase 19 (USP19) is upregulated during muscle atrophy and by E 2 -activated ERa. Here, we investigated the involvement of USP19 in sex difference in muscle mass in young mice. Knockdown of USP19 in hindlimb muscles increased the mass and fiber size in soleus muscle in females but not males. Using Usp19 promoter reporter constructs, a functional half-estrogen response element (hERE) was identified in intron 1 of Usp19. ERa bound to hERE in an E 2 -dependent manner in C2C12 myoblasts and in soleus muscle in ovariectomized (OVX) female mice. Furthermore, under normal physiological conditions, ERa bound to hERE in soleus muscle only in females. In contrast, administration of E 2 resulted in increased Usp19 mRNA expression, decreased muscle mass, and recruitment of ERa to hERE in soleus muscle in males. Knockdown of ERa in hindlimb muscles decreased Usp19 mRNA expression and increased the mass of soleus muscle only in females. Knockdown of USP19 resulted in increased levels of ubiquitin conjugates in soleus muscle in females. OVX increased the levels of ubiquitin conjugates and administration of E 2 decreased OVX-induced levels of ubiquitin conjugates. These results demonstrate that in soleus muscle in young female mice under physiological conditions, E 2 upregulates USP19 expression through ERa and consequently leads to decreases in ubiquitin conjugates and muscle mass. Key Words " skeletal muscle " estrogen receptor a " ubiquitin-specific peptidase 19 " muscle hypertrophy Cells were incubated in steroid-free differentiation medium in the presence or absence of E 2 , and the luciferase activity was determined. (D) C2C12 cells were cultured in steroid-free differentiation medium in the present or absence of E 2 . The protein-DNA complexes were cross-linked and immunoprecipitated with control (CTL) IgG or anti-ERa (ERa) IgG. Immunoprecipitated DNA was analyzed by qPCR. (B, C, and D). Values are indicated as meansGS.D. (nZ3), and bars not sharing a common letter are significantly different (P!0.05 by one-way ANOVA with Tukey's test).
Introduction
Body composition and body size are different between males and females. Sex hormones such as androgens and estrogens are thought to be responsible for sex-specific differences not only in reproductive tissues, but also in peripheral tissues such as skeletal muscle, adipose, and bone (Heldring et al. 2007 ). Administration of the estrogen 17b-estradiol (E 2 ) reduces soleus muscle fiber size in young ovariectomized (OVX) female rats (McCormick et al. 2004) and decreases soleus muscle mass in young female mice (Ihemelandu 1981) . We previously reported that E 2 replacement decreases the muscle mass in young OVX mice ). However, the mechanism by which E 2 decreases skeletal muscle mass in young females is unclear. Therefore, it is important to identify and characterize target molecules that regulate skeletal muscle mass in a sex-specific fashion in young female mice.
Skeletal muscle is the largest tissue in all mammals and accounts for 30-40% of the whole body weight in humans. Because this tissue plays important roles in not only mobility, but also metabolism of glucose and triglyceride, the loss of muscle mass results in decreased mobility, ultimately immobility and metabolic diseases such as obesity and type 2 diabetes (Bergeron et al. 1999 , Kiens 2006 , Srikanthan et al. 2010 . During embryogenesis, the myoblasts fuse into multinucleated myotubes that eventually form myofibers (called myogenesis) (Abmayr & Pavlath 2012) . Postnatal growth of skeletal muscle is achieved by either extensive fusion of myoblasts with the growing myofibers (hyperplasia) or an increase in the size of individual myofibers (hypertrophy) (White et al. 2010) . In mice, hyperplasia stops around 3 weeks after birth (Gokhin et al. 2008) , and then hypertrophy mainly contributes to an increase in skeletal muscle mass (Ontell et al. 1984) . Hypertrophy occurs due to increased net protein within an individual myofiber with no addition of myonuclei.
Skeletal muscle mass is regulated by the balance between synthesis and degradation of muscle proteins, and the loss of muscle mass results from increased protein degradation (Evans 2010) . The ubiquitin-proteasome system serves to degrade aberrant proteins. The conjugation of ubiquitin to muscle proteins is accomplished by a cascade of enzymes, ubiquitin-activating enzymes, ubiquitin-conjugating enzymes, and ubiquitin ligases, and subsequently the conjugated proteins are degraded by the proteasome (Hershko & Ciechanover 1992) . In addition, deubiquitinating enzymes, which are called ubiquitinspecific peptidases (USPs), also regulate the ubiquitinproteasome system. The USPs release ubiquitin from nonspecific ubiquitin-conjugated proteins to maintain intracellular ubiquitin level or remove ubiquitin from specific ubiquitin-conjugated proteins to protect them from proteasomal degradation (Tiao et al. 1997) . The expression levels of two deubiquitinating enzymes, USP14 and USP19, are increased in skeletal muscle during catabolic states (Combaret et al. 2005 , Srikanthan et al. 2010 , Liu et al. 2011 , Ogawa et al. 2013 . Overexpression of USP19 inhibits myogenesis, whereas depletion of USP19 promotes myogenesis ) and inhibits dexamethasone-induced muscle atrophy in L6 cells (Sundaram et al. 2009 ).
The biological functions of E 2 are exerted through its binding to two estrogen receptors (ERs), ERa and ERb (Heldring et al. 2007 ). The ERs bind to estrogen response elements (EREs) in the promoter regions of estrogenresponsive genes, followed by transcriptional activation of their genes (Heldring et al. 2007 ). The EREs are palindromic sequences and sometimes one half of the ERE (hERE) is effective. Because ERa and ERb competitively bind to the same EREs or specifically bind to different EREs, they do not function redundantly in gene regulation. The two ER isoforms are expressed in the skeletal muscle (Wiik et al. 2009 ) and seem to play different biological roles in skeletal muscle development (Barros et al. 2006 , Brown et al. 2009 ). We previously found that E 2 represses myogenic differentiation, which occurs during developmental and postnatal myogenesis, by increasing Usp19 gene expression through ERa and that E 2 replacement increases USP19 expression level in soleus muscle in young OVX mice . These findings led us to study the roles of ERa and USP19 in skeletal muscle mass in young male and female mice under physiological conditions. The purpose of this study was to determine how ERa upregulates Usp19 gene expression and whether USP19 is involved in difference in skeletal muscle mass between males and females in young mice. Our data provide evidence that ERa upregulates Usp19 gene expression in young female mice, but not in male mice, in an E 2 -dependent manner under physiological conditions and that consequently USP19 decreases soleus muscle mass in young females.
Materials and methods

Animals
The care of all animals in the present study was in accordance with the guidelines of the Animal Care and Use Committee of Osaka Prefecture University. Female Kwl:ddY mice and male Kwl:ddY mice were obtained from Kiwa Laboratory Animals (Wakayama, Japan) at 6 weeks of age and at 7 weeks of age, respectively. The mice had free access to water and food (phytoestrogen-free AIN76 diet (Lephart et al. 2004) in which sucrose was replaced with cornstarch). The mice were kept at controlled temperature (23G2 8C), humidity (60G10%) and lighting (a 12 h light:12 h darkness cycle starting at 0800 h).
Ovariectomy and E 2 injection
Female mice at 7 weeks of age were OVX and were randomly divided into two groups (nZ5 per group). After 1 week, one group was injected with estradiol valerate (0.1 mg/kg body weight; Mochida Pharmaceutical, Tokyo, Japan) into the thigh muscles. The other group was intramuscularly injected with vehicle (sesame oil).
Two groups (nZ5 per group) of male mice at 8 weeks of age were treated in the same way. One week after injection, the mice were sacrificed by exsanguination under anesthesia. The soleus muscles were isolated, weighed, frozen in liquid nitrogen, and stored at K80 8C until use.
Cell culture
Mouse C2C12 skeletal muscle myoblasts were obtained from RIKEN Cell Bank (Tsukuba, Japan) and were maintained as previously described . Briefly, C2C12 myoblasts were grown to confluence in DMEM supplemented with 10% v/v fetal bovine serum, 100 units/ml penicillin, and 100 mg/ml streptomycin (growth medium) at 37 8C in 5% CO 2 and 95% air atmosphere at 100% humidity. To induce differentiation, C2C12 myoblasts were grown to 90% confluence in the growth medium and then cultured in DMEM supplemented with 2% v/v horse serum (differentiation medium) unless otherwise indicated. The differentiation medium was replaced at 48 h intervals.
Construction of reporter vectors and promoter assay
The nucleotide sequence (K152 to C1902) including a putative hERE (C301 to C306) in murine Usp19 gene was amplified by PCR using genomic DNA from C2C12 myoblasts. The amplified DNA was subcloned into pGL4.20 plasmid (Promega), termed pUSP19-hERE. A portion of the putative hERE was mutated by site-directed mutagenesis from 5 0 -AGGTCA-3 0 to 5 0 -AGAGCA-3 0 , and the resultant mutated DNA was subcloned into pGL4.20 vector, termed pUSP19-mhERE. C2C12 myoblasts were cultured in steroid-free differentiation medium, which was composed of phenol red-free DMEM supplemented with 2% v/v dextran-coated charcoal-stripped horse serum, on 48-well plates, and transiently transfected with each reporter vector using HilyMax (Dojindo, Kumamoto, Japan) for 24 h, and incubated in fresh medium containing 10 nmol/l E 2 for an additional 24 h. Luciferase activity was determined as described previously . Transfection efficiency was normalized with Renilla luciferase expression vector (pGL4.73[hRluc/SV40]; Promega), and data were expressed as relative light units (RLU, firefly luciferase activity divided by Renilla luciferase activity).
In vivo siRNA-mediated knockdown
Murine USP19 siRNA (siUSP19), murine ERa siRNA (siERa), and control siRNA (siCTL; catalog number S21-25P) were purchased from Koken (Tokyo, Japan). The sequences of siUSP19 and siERa were described previously . siUSP19 or siERa was transfected to the right hindlimb muscle, and control siRNA was transfected to the left hindlimb muscle using atelocollagen (AteloGene Local Use; Koken) at 8 weeks of age (nZ5 per sex). Atelocollagen complexed with siRNA was prepared as follows: 0.05% w/v atelocollagen was mixed with an equal volume of siRNA solution (10 mmol/l). The hindlimb was injected with 100 ml atelocollagen-siRNA complex at multiple sites. After 1 week, mice were sacrificed by exsanguination under anesthesia. The soleus muscles were isolated, weighed, frozen in liquid nitrogen, and stored at K80 8C until use.
In vitro siRNA-mediated knockdown
Murine ERa (siERa) and control siRNA (siCTL) were purchased from Sigma-Aldrich as described previously . The siRNA duplexes at concentrations of 10 nM were introduced into C2C12 myotubes using Lipofectamine RNAiMAX reagent and Opti-MEM (Invitrogen). After siRNA treatment for 6 h, culture medium was replaced by fresh steroid-free differentiation medium.
Histological analysis and morphometric measurements
Soleus muscles were dissected from female and male mice (nZ5 per hindlimb), immediately fixed in 10% formalin, embedded in paraffin, sectioned at 4 mm, and stained with hematoxylin and eosin. Images of the muscle sections were obtained with a BIOREVO BZ-9000 microscope (Keyence, Osaka, Japan). The cross-sectional area (CSA) (mm 2 ) of muscle fibers was measured using ImageJ software (version 1.44p; National Institutes of Health, Bethesda, MD, USA). Mean fiber CSA was determined from approximately 250 fibers per soleus muscle.
Serum E 2 measurement
Blood was collected from female and male mice (nZ5 per sex) and incubated at 37 8C. After 1 h, serum was separated by centrifugation at 3000 g for 10 min. E 2 was extracted from serum using hexane-ethyl acetate (3:2 by volume). The organic extract containing E 2 was dried under N 2 gas and dissolved in methanol. Serum E 2 levels were measured using an estradiol ELISA kit (Tokiwa Chemical Industries, Tokyo, Japan).
RNA isolation and quantitative RT-PCR analysis
Total RNA was isolated from soleus muscle (nZ5 per sex) using Sepasol-RNA I Super G (Nacalai Tesque, Kyoto, Japan), and reverse-transcribed. The resultant cDNAs were subjected to quantitative PCR (qPCR) using the following specific primers: Usp19 (forward primer 5 0 -GCGGCACAA-GATGAGAAATG-3 0 and reverse primer 5 0 -ACCAGGAACT-TGATGGGCTT-3 0 ), ERa (forward primer 5 0 -ATGATTGGT-CTCGTCTGGCGCT-3 0 and reverse primer 5 0 -AGCAGGT-CATAGAGGGGCACAACG-3 0 ), and peptidylprolyl isomerase A (Ppia) (forward primer 5 0 -GCAAATGCTGGACCAAA-CAC-3 0 and reverse primer 5 0 -TCACCTTCCCAAAGACCA-CAT-3 0 ). The PCR profiles consisted of denaturation at 95 8C for 1 min, primer-annealing at 57 8C for 1 min, and primer extension at 72 8C for 30 s. The final primer extension was performed at 72 8C for 10 min. The PCR in qPCR was performed with a Plexor One-Step qRT-PCR System (Promega) on a Thermal Cycler Dice, TP-800 (Takara Bio, Shiga, Japan). Ct values were transformed into relative quantification data by the 2 KDDCt method. The Ct value of Ppia was used as an internal control (Nishimura et al. 2008) .
Western blotting
Soleus muscle from male and female mice (nZ3 per hindlimb) was homogenized in lysis buffer (50 mmol/l Tris-HCl, pH 7.5, containing 150 mmol/l NaCl, 0.25% w/v sodium deoxycholate, 1% w/v NP-40, 0.1% w/v SDS, 1 mmol/l EDTA, 25 mmol/l NaF, 1 mmol/l Na 3 VO 4 , 1 mmol/l 4-(2-aminoethyl) benzenesulfonyl fluoride, 10 mg/ml leupeptin, and 1 mg/ml aprotinin). The homogenates were subjected to SDS-PAGE and analyzed by western blotting with mouse monoclonal antiubiquitin IgG (FK2; Nippon Biotest Laboratories, Tokyo, Japan). Immunoreactive proteins were incubated with HRP-conjugated goat anti-mouse IgG and reacted with Immobilon Western Chemiluminescent HRP Substrate (Millipore, Billerica, MA, USA), followed by detection with an ImageQuant LAS 4000 imaging system (GE Healthcare, Uppsala, Sweden). The levels of ubiquitin conjugates were quantified by densitometry using ImageJ software.
Chromatin immunoprecipitation assay
C2C12 myotubes were incubated in steroid-free differentiation medium containing 10 nmol/l E 2 for 30 min, followed by fix with 1% paraformaldehyde. The frozen skeletal muscle tissues were crushed, followed by incubation with 1% w/v paraformaldehyde. Cells were lysed, and tissues were homogenized in SDS-lysis buffer (50 mmol/l Tris-HCl, pH 8.0, containing 1% w/v SDS, 10 mmol/l EDTA, 1 mmol/l 4-(2-aminoethyl) benzenesulfonyl fluoride, 10 mg/ml leupeptin, and 1 mg/ml aprotinin) as described previously . In brief, lysates and homogenates were sonicated (Handy Sonic UR-21P; Tomy Seiko, Tokyo, Japan) to shear the DNA, followed by centrifugation at 20 000 g for 3 min. The supernatant was diluted tenfold with chromatin immunoprecipitation (ChIP) dilution buffer and pre-cleared with 40 ml of protein G-Sepharose resin (50% w/v slurry; GE Healthcare) for 1 h at 4 8C. The supernatant was reacted with rabbit polyclonal anti-ERa (MC20; Santa Cruz Biotechnology) or control IgG overnight at 4 8C and incubated with 40 ml of protein G-Sepharose resin (50% w/v slurry) for 1 h. The resin was sequentially washed. Immunoprecipitated complexes with anti-ERa or control IgG were eluted with elution buffer. Immunoprecipitated DNA was analyzed by qPCR. Primers used for qPCR were as follows: forward primer 5 0 -TGAGTGGTGTGGGCCT-CAAGTC-3 0 and reverse primer 5 0 -TAGCATAACG-GCTCGGTCGGCA-3 0 . The PCR in qPCR was performed, and Ct values were obtained as previously described. Signals obtained from the ChIP sample were divided by signals obtained from an input sample and expressed as relative values.
Statistical analysis
The significance of difference between two groups was determined with Student's t-test. One-way ANOVA with Tukey's post hoc testing was used in experiments that had three or more groups. Statistical analysis was performed using JMP statistical software version 8.0.1 (SAS Institute, Cary, NC, USA). Data are expressed as meansGS.D., and differences were considered statistically significant at P values!0.05.
Results
USP19 knockdown increases the mass and size of soleus muscle in female mice
In soleus muscle, Usp19 mRNA levels were significantly higher in female mice than in male mice (Fig. 1A) . To address the role of USP19 in the soleus muscle mass, USP19 siRNA was transfected into soleus muscle of male and female mice. The mRNA expression of Usp19 was knocked down in soleus muscle (Fig. 1B) . Knockdown of USP19 increased the mass of the soleus muscle in females, but not in males (Fig. 1C) . Furthermore, to determine the effect of USP19 expression on size of muscle fiber, the CSA of each muscle fiber was quantitated. In females and males, the frequency distribution of CSA of fibers was shifted toward larger sizes in USP19 siRNA-treated soleus muscle than in control siRNA-treated soleus muscle, but knockdown of USP19 significantly increased the CSA of soleus muscle fiber only in females (Fig. 1D) . These results indicate that USP19 represses the mass and size of soleus muscle only in female mice. E 2 induces the binding of ERa to half-ERE in Usp19 gene in C2C12 myoblasts Intron 1 of Usp19 was found to contain one potential half-ERE (hERE) by rVISTA (Loots et al. 2002) . To evaluate whether it is functional, we constructed two luciferase reporter vectors composed of the nucleotide sequence from K152 to C1902, one with authentic hERE sequence and the other with the mutated hERE (mhERE) sequence ( Fig. 2A) , and termed pUSP19-hERE and pUSP19-mhERE, respectively. E 2 increased luciferase activity in the pUSP19-hERE-transfected cells, but not in the pUSP19-mhERE-transfected cells (Fig. 2B) , and the increase was abolished by ERa knockdown (Fig. 2C) . In a ChIP assay, ERa bound to hERE only in the presence of E 2 (Fig. 2D) . These results indicate that the hERE in intron 1 of Usp19 gene is functional and that E 2 promotes the binding of ERa to hERE in Usp19 gene.
ERa is recruited to hERE in Usp19 gene in soleus muscle in females
In soleus muscle, the expression levels of ERa were similar between female and male mice (Fig. 3A) . A ChIP analysis showed that ERa bound to hERE in Usp19 in soleus muscle in female mice, but not in male mice (Fig. 3B ). Furthermore, ERa did not bind to hERE in Usp19 gene in OVX female mice, whereas ERa was recruited to hERE when OVX mice were injected with E 2 (Fig. 3C) . In male mice, administration of E 2 increased the mRNA levels of Usp19 in soleus muscle (Fig. 3D ) and decreased the mass of soleus muscle (Fig. 3E ). E 2 resulted in the recruitment of ERa to hERE in male mice (Fig. 3F) . Serum E 2 concentration was decreased by ovariectomy and restored by administration of E 2 (Fig. 3G ). E 2 concentration in male mice was similar to that in OVX female mice, but was increased to that in female mice by E 2 administration.
These results indicate that ERa is recruited to hERE in Usp19 in soleus muscle only in female mice in an E 2 -dependent manner under physiological conditions.
ERa knockdown increases soleus muscle mass by repressing USP19 expression in female mice
To address the role of ERa in skeletal muscle mass, ERa siRNA was transfected into skeletal muscle. ERa siRNA specifically knocked down the expression of ERa mRNA in soleus muscle of male and female mice (Fig. 4A ). Knockdown of ERa decreased the expression level of Usp19 mRNA in soleus muscle only in female mice (Fig. 4B ). Furthermore, knockdown of ERa increased the mass of soleus muscle only in female mice (Fig. 4C) . These results indicate that in females, a decrease in ERa increases the mass of soleus muscle by down-regulating USP19 expression.
USP19 and E 2 are involved in the levels of ubiquitin conjugates
We determined whether USP19 regulates the levels of ubiquitin conjugates in soleus muscle under physiological conditions. In soleus muscle transfected with control siRNA, the levels of ubiquitin conjugates were not significantly different between females and males ( Fig. 5A ). However, knockdown of USP19 resulted in increased levels of ubiquitin conjugates in females, but not in males. Furthermore, OVX increased the levels of ubiquitin conjugates, and administration of E 2 restored OVX-increased levels of ubiquitin conjugates (Fig. 5B) .
These results indicate that USP19 contributes to deubiquitination reaction in an E 2 -dependent manner in females, but not in males.
Discussion
Sex hormones contribute to the sex differences in body weight and composition between men and women. Although there are sex-related differences in gene expression in human skeletal muscle (Deasy et al. 2008 , Welle et al. 2008 , the molecular mechanisms underlying the quantitative difference between male and female skeletal muscles remain largely unknown. In this study, we demonstrate that USP19 is a potent down-regulator of muscle mass in young female mice. Knockdown of USP19 increased the muscle mass only in young female mice under normal physiological conditions (Fig. 1C) . Skeletal muscle mass and muscle proteins are decreased under pathophysiological conditions such as fasting, diabetes, cancer, and disuse (Bonaldo & Sandri 2013) . Muscle atrophy induces the expression of atrophy-related genes (atrogenes) such as muscle-specific E 3 ubiquitin ligases (MAFbx/atrogin-1 and MuRF1) (Bodine et al. 2001) . The expression of USP19 is increased in skeletal muscle atrophying in response to fasting, diabetes, dexamethasone treatment, cancer, and denervation in male rodents (Combaret et al. 2005 , Ogawa et al. 2013 . Furthermore, administration of E 2 to OVX mice increases USP19 expression to the control level and decreases the mass of soleus muscle . These show that USP19 is an atrophy-related gene. On the other hand, with respect to myogenesis, overexpression of USP19 decreases the expression levels of myofibrillar proteins in C2C12 myoblasts and represses myogenesis, whereas depletion of USP19 increases the expression level of myogenin, which is the myogenic transcriptional factor, and promotes the synthesis of myofibrillar proteins . Furthermore, in C2C12 myoblasts, E 2 increases USP19 expression and represses myogenesis, whereas knockdown of USP19 restores E 2 -decreased levels of myofibrillar proteins . Three conclusions can be drawn from these results: USP19 acts as i) a negative regulator of muscle mass in young female mice under normal physiological conditions; ii) a negative regulator of muscle mass in male mice, and perhaps also in female mice, under pathophysiological conditions; iii) a repressor of myogenesis. Cellular responses to E 2 are elicited through genomic and non-genomic mechanisms. Genomic mechanisms refer to the transcriptional activation of target genes through the binding of ERs (ERa and ERb) to palindromic EREs of their target gene promoters in the nucleus (Hewitt & Korach 2002) . Besides palindromic EREs, ERa or ERb regulates the expression of prothymosin (Martini & Katzenellenbogen 2001) , cathepsin D , ovalbumin (Kato et al. 1992) , and progesterone receptor (Petz & Nardulli 2000) through binding to hEREs. Nongenomic mechanisms refer to rapid cellular responses (e.g., calcium mobilization, kinase activation, and nitric oxide production) induced not only by extranuclear ERs but also by a membrane-associated G-protein-coupled receptor known as GPR30 (Prossnitz et al. 2008 ). These responses occur on a timescale of seconds to minutes, whereas the genomic responses occur on a timescale of hours. E 2 increases USP19 expression through ERa during myogenesis . ERa bound to a hERE in intron 1 of Usp19 gene in an E 2 -dependent manner in C2C12 cells ( Fig. 2D ) and in muscles of OVX mice (Fig. 3C) , indicating that the genomic response of ERa regulates USP19 expression in an E 2 -dependent manner. Furthermore, knockdown of ERa decreased the USP19 expression ( Fig. 4B ) and increased the mass in the soleus muscle (Fig. 4C) in females under physiological conditions. Therefore, these results indicate that the expression of USP19 is regulated by ERa in the soleus muscle under physiological conditions. Knockdown of USP19 induced hypertrophy in skeletal muscle of young female mice (Fig. 1D ). After birth, skeletal muscle mass primarily increases by hypertrophy in muscle fiber (Ontell et al. 1984 , White et al. 2010 . Muscle hypertrophy occurs when the overall rate of protein synthesis exceeds the rate of protein degradation. Increases in protein degradation are involved in the loss of skeletal muscle mass. The ubiquitin-proteasome system contributes to the majority of protein degradation. During muscle atrophy, the expression of MAFbx/atrogin-1 and MuRF1 is upregulated and promotes ubiquitination of proteins (Bodine et al. 2001 , Bonaldo & Sandri 2013 . In functional overload model mice, depletion of MAFbx/ atrogin-1, but not MuRF1, attenuates overload-induced growth in plantaris muscle only in females (Baehr et al. 2014) . MAFbx/atrogin-1 mediates ubiquitination of MyoD and eIF3-f (Tintignac et al. 2005 , Csibi et al. 2008 , and MuRF1 contributes to ubiquitination of troponin I, b/slow myosin heavy chain, myosin heavy chain IIa, and actin (Kedar et al. 2004 , Fielitz et al. 2007 , Polge et al. 2011 . These results suggest that the quantity and quality of ubiquitinated proteins are different between males and females although they may depend on the situations, such as when the mice are subjected to a functional overload.
In the present study, there was no significant difference of ubiquitin conjugates between females and males under physiological conditions, whereas knockdown of USP19 resulted in higher levels of ubiquitin conjugates in females than in males (Fig. 5 ). In addition, USP19 depletion had no effect on muscle mass and size in male mice under physiological conditions (Fig. 1C and D) . USP14 seems to remove and recycle ubiquitin from non-specific ubiquitinconjugated proteins on the proteasome because USP14 is associated with the proteasome (Peth et al. 2009 ). In contrast, USP19 appears to remove ubiquitin from specific ubiquitin-conjugated substrate proteins and protect them from proteasomal degradation because it does not appear to be associated with the proteasome (Sundaram et al. 2009 ). Instead, USP19 is associated with several proteins, such as cellular inhibitors of apoptosis (cIAP1 and cIAP2) (Mei et al. 2011) , endoplasmic-reticulum-associated degradation substrates (Hassink et al. 2009 ) and heat shock protein 90 (Lee et al. 2014) . These results suggest that, under normal physiological conditions, USP19 substrate proteins regulating muscle mass are weakly expressed or weakly ubiquitinated in male mice.
In contrast, administration of E 2 to male mice resulted in an increased USP19 expression and a decreased soleus muscle mass (Fig. 3D ). Sex hormones are involved in the differential regulation of gene expression in human skeletal muscle cells (Deasy et al. 2008 , Welle et al. 2008 . This, together with the present results, suggest that the USP19 substrate proteins regulating muscle mass are ubiquitinated or expressed in an E 2 -dependent manner. Systematic ERa knockout decreases the soleus muscle mass normalized to body mass, and total protein and myosin content are similar between systematic ERa knockout mice and WT mice that are 5-8 months old (Brown et al. 2009 ). Furthermore, in aged (4 months of age) OVX female mice, E 2 replacement improves OVXinduced declines in hindlimb muscle contractility (Moran et al. 2007 ). These results are contradictory to our finding that in young female mice (8 weeks of age), knockdown of ERa increased soleus muscle mass normalized to body mass (Fig. 4C ). The contradictory results regarding the effects of E 2 on skeletal muscle mass may be due to the difference in age of mice used in each study. We are presently attempting to study the effects of E 2 on skeletal muscle mass in aged females.
In conclusion, in young female mice, the knockdown of USP19 resulted in an increase in soleus muscle mass, and ERa increased the levels of USP19 at the transcriptional level (Fig. 6) . These results indicate that USP19 is a potent down-regulator of muscle mass in young female mice. Identification of the substrate proteins of USP19 should elucidate the sex-specific regulation of skeletal muscle mass in young females.
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